Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 2,497 KNSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,497 | n/a |
| May 5, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 58,424 | $605.3K |
| Apr 8, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 2,497 | n/a |
| Apr 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 5,831 | n/a |
| Mar 4, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 40,000 | $414.4K |
| Nov 4, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 36,542 | $138.9K |
| Sep 3, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 1,750 | n/a |
| Aug 8, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 29,325 | $111.4K |
| May 9, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 200 | $760.00 |
| May 5, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/Award | 4,954 | n/a |